EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BLU, TRIL, and BHC
Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Bausch Health Companies (BHC). These companies are all part of the "medical" sector.
Extendicare vs.
Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.
Extendicare currently has a consensus price target of C$12.50, suggesting a potential downside of 5.37%. dentalcorp has a consensus price target of C$12.22, suggesting a potential upside of 54.52%. Given dentalcorp's stronger consensus rating and higher possible upside, analysts clearly believe dentalcorp is more favorable than Extendicare.
Extendicare has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, dentalcorp has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.
19.2% of Extendicare shares are held by institutional investors. Comparatively, 50.3% of dentalcorp shares are held by institutional investors. 13.9% of Extendicare shares are held by insiders. Comparatively, 0.2% of dentalcorp shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Extendicare has higher earnings, but lower revenue than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.
Extendicare received 116 more outperform votes than dentalcorp when rated by MarketBeat users. However, 64.81% of users gave dentalcorp an outperform vote while only 47.34% of users gave Extendicare an outperform vote.
Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.
In the previous week, Extendicare had 3 more articles in the media than dentalcorp. MarketBeat recorded 3 mentions for Extendicare and 0 mentions for dentalcorp. Extendicare's average media sentiment score of 0.47 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the media.
Summary
Extendicare beats dentalcorp on 10 of the 17 factors compared between the two stocks.
Get Extendicare News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Extendicare Competitors List
Related Companies and Tools
This page (TSE:EXE) was last updated on 4/23/2025 by MarketBeat.com Staff
Buy EXE Stock Free EXE Stock Alerts